14
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T32106 | Human beta-amyloid protein 42 (1-7) | Vanutide | |
Human beta-amyloid protein 42 (1-7) is a bioactive chemical. | |||
TP1359L | Amyloid β Peptide (42-1)(human) acetate | Amyloid β Peptide (42-1)(human) acetate(317366-82-8 free base) | Beta Amyloid |
Amyloid β Peptide (42-1)(human) acetate is the inactive form of Amyloid β Peptide (1-42). Amyloid β Peptide (42-1)(human) acetate is a 42-amino acid peptide which plays a key role in the pathogenesis of Alzheimer disease... | |||
T35499 | β-Amyloid (1-42), (rat/mouse) (TFA) | Amyloid β-peptide (1-42) (human) TFA,166090-74-0 TFA | |
β-Amyloid (1-42), (rat/mouse) (TFA) is a peptide fragment consisting of 42 amino acids that can be used to study Alzheimer's disease. | |||
TP1359 | β-Amyloid (42-1), human | Amyloid β Peptide (42-1)(human) | |
Amyloid β-Peptide (1-42) human is a 42-amino acid peptide which plays a key role in the pathogenesis of Alzheimer disease. | |||
TP1007 | β-Amyloid (1-42), human | β-Amyloid (1-42), human,Amyloid β-Peptide (1-42) human | Beta Amyloid |
Amyloid β-Peptide (1-42) human is a 42-amino acid peptide which plays a key role in the pathogenesis of Alzheimer disease. | |||
T37768 | β-Amyloid (1-37) (human) | ||
β-Amyloid (1-37) (human) Potentially associated with mental status in Alzheimer's disease. | |||
T38149 | β-Amyloid (1-43)(human) | ||
The amyloid β-protein is a 39- to 43-amino acid polypeptide that is the primary constituent of senile plaques and cerebrovascular deposits in Alzheimer's disease and Down's syndrome. Additionally it acts as an inhibitor ... | |||
T37370 | Amyloid-β (25-35) Peptide (human) (trifluoroacetate salt) | ||
Amyloid-β (25-35) (Aβ (25-35)) is an 11-residue fragment of the Aβ protein that retains the physical and biological characteristics of the full length peptide. It forms fibrils that react to thioflavin T and Congo red an... | |||
T77042 | Aducanumab | BIIB037 | Beta Amyloid |
Aducanumab (BIIB037), A selective human immunoglobulin gamma-1 (IgG1) monoclonal antibody, targets the clustered form of amyloid beta (Aβ). Aducanumab shows brain permeability and may be used to treat Alzheimer's disease... | |||
T13253 | Umibecestat | CNP520 | BACE |
Umibecestat is an inhibitor of beta-site amyloid precursor protein cleaving enzyme-1 (BACE-1), with IC50s of 11 nM and 10 nM for human BACE-1 and mouse BACE-1, respectively. Umibecestat can be used for the research of al... | |||
T31828 | AZD4694 | Flutafuranol,AZD 4694,NAV-4694,AZD-4694,NAV 4694,NAV4694 | |
Flutafuranol, also known as AZD 4694 and NAV4694, is a bio-active chemical. AZD4694 shows high affinity for beta-amyloid fibrils in vitro (K(d) = 2.3 +/- 0.3 nM). The fluorine-18 labeled AZD4694 may have potential for PE... | |||
T80701 | β Amyloid (1-16) rat | ||
β-Amyloid (1-16) rat is a fragment of the metal-binding domain of the amyloid beta (Abeta) peptide. It contains three amino acid substitutions that distinguish it from its human counterpart, conferring reduced susceptibi... | |||
T82242 | HAChE-IN-6 | ||
hAChE-IN-6 (compound 51) is a brain-penetrant acetylcholinesterase (AChE) inhibitor exhibiting an IC50 of 0.16 μM. It also demonstrates inhibitory effects on human butyrylcholinesterase (hBuChE) and glycogen synthase kin... | |||
T82243 | HAChE-IN-5 | GSK-3 | |
hAChE-IN-5 (compound 49) is a dual inhibitor of human acetylcholinesterase (hAChE) and human butyrylcholinesterase (hBuChE), exhibiting inhibitory potency with IC50 values of 0.17 μM for both enzymes. Additionally, it de... |